Dallah Healthcare Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line

Dallah Healthcare (TADAWUL:4004) Third Quarter 2024 Results

Key Financial Results

• Revenue: ر.س847.7m (up 13% from 3Q 2023).
• Net income: ر.س126.2m (up 28% from 3Q 2023).
• Profit margin: 15% (up from 13% in 3Q 2023). The increase in margin was driven by higher revenue.
• EPS: ر.س1.29 (up from ر.س1.01 in 3Q 2023).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Dallah Healthcare Earnings Insights

Looking ahead, revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Healthcare industry in Saudi Arabia.

Performance of the Saudi Healthcare industry.

The company's shares are down 2.4% from a week ago.

Risk Analysis

We should say that we've discovered 1 warning sign for Dallah Healthcare that you should be aware of before investing here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.